Tormod Fladby

Overview

Best Publications

• Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.

  Iris E. Jansen;Jeanne E. Savage;Kyoko Watanabe;Julien Bryois

  2416
  Citations

• Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.

  Willemijn J. Jansen;Rik Ossenkoppele;Dirk L. Knol;Betty M. Tijms

  1712
  Citations

• Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease

  E F Fang;Y Hou;K Palikaras;B A Adriaanse

  1561
  Citations

• A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease.

  Douglas P Wightman;Iris E Jansen;Jeanne E Savage;Alexey A Shadrin

  1034
  Citations

• A Practical Guide to Immunoassay Method Validation

  Ulf Andreasson;Armand Perret-Liaudet;Linda J C van Waalwijk van Doorn;Kaj Blennow

  549
  Citations

• EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia

  S. Sorbi;J. Hort;T. Erkinjuntti;T. Erkinjuntti;T. Fladby

  413
  Citations

• Loss-of-function variants in ABCA7 confer risk of Alzheimer's disease

  Stacy Steinberg;Hreinn Stefansson;Thorlakur Jonsson;Hrefna Johannsdottir

  368
  Citations

• Glial activation and inflammation along the Alzheimer's disease continuum.

  Kaja Nordengen;Bjørn Eivind Kirsebom;Kristi Henjum;Per Selnes

  272
  Citations

• Mild Cognitive Impairment in Parkinson’s Disease

  Dag Aarsland;Kolbjørn Brønnick;Tormod Fladby;Tormod Fladby

  234
  Citations

• Genetic overlap between Alzheimer's disease and Parkinson's disease at the MAPT locus.

  R.S. (R. S.) Desikan;A.J. (A. J.) Schork;Y. Wang;Y. Wang;Aree Witoelar

  185
  Citations

• Drug repositioning and repurposing for Alzheimer disease

  Clive Ballard;Dag Aarsland;Dag Aarsland;Jeffrey Cummings;John O’Brien

  184
  Citations

• Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease.

  Rahul S. Desikan;Andrew J. Schork;Yunpeng Wang;Yunpeng Wang;Wesley K. Thompson

  169
  Citations

• EFNS‐ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease

  Reinhold Schmidt;Edith Hofer;F. H. Bouwman;K. Buerger

  168
  Citations

• Cerebrospinal fluid soluble TREM2 in aging and Alzheimer's disease

  Kristi Henjum;Ina S. Almdahl;Vibeke Årskog;Lennart Minthon

  165
  Citations

• Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia.

  Willemijn J Jansen;Rik Ossenkoppele;Betty M Tijms;Anne M Fagan

  157
  Citations

• Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer's disease.

  N Siafarikas;G Selbaek;T Fladby;J Šaltytė Benth

  144
  Citations

• Cerebrospinal Fluid Alzheimer's Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort.

  Inger van Steenoven;Dag Aarsland;Daniel Weintraub;Elisabet Londos

  136
  Citations

• Early and Presenting Symptoms of Dementia with Lewy Bodies

  Eirik Auning;Arvid Rongve;Tormod Fladby;Jan Booij

  130
  Citations

• Connectome-wide network analysis of youth with Psychosis-Spectrum symptoms.

  T D Satterthwaite;S N Vandekar;D H Wolf;D S Bassett

  128
  Citations

• White matter imaging changes in subjective and mild cognitive impairment.

  Per Selnes;Anders M. Fjell;Anders M. Fjell;Leif Gjerstad;Atle Bjørnerud;Atle Bjørnerud

  113
  Citations

• Multimodal imaging in mild cognitive impairment: Metabolism, morphometry and diffusion of the temporal-parietal memory network

  Kristine B. Walhovd;Anders M. Fjell;Inge K. Amlien;Ramune Grambaite;Ramune Grambaite

  112
  Citations